Display options
Share it on

Neth Heart J. 2022 Jan 05; doi: 10.1007/s12471-021-01654-8. Epub 2022 Jan 05.

Introduction of a new scoring tool to identify clinically stable heart failure patients.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

A J Gingele, L Brandts, H P Brunner-La Rocca, G Cleuren, C Knackstedt, J J J Boyne

Affiliations

  1. Department of Cardiology, Maastricht University Medical Centre+, Maastricht, The Netherlands. [email protected].
  2. Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  3. Department of Cardiology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  4. Department of Patient and Care, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  5. Department of Health Services Research, CAPHRI, Maastricht University, Maastricht, The Netherlands.

PMID: 34988879 DOI: 10.1007/s12471-021-01654-8

Abstract

INTRODUCTION: Heart failure (HF) poses a burden on specialist care, making referral of clinically stable HF patients to primary care a desirable goal. However, a structured approach to guide patient referral is lacking.

METHODS: The Maastricht Instability Score-Heart Failure (MIS-HF) questionnaire was developed to objectively stratify the clinical status of HF patients: patients with a low MIS-HF (0-2 points, indicating a stable clinical condition) were considered for treatment in primary care, whereas high scores (> 2 points) indicated the need for specialised care. The MIS-HF was evaluated in 637 consecutive HF patients presenting between 2015 and 2018 at Maastricht University Medical Centre.

RESULTS: Of the 637 patients, 329 (52%) had a low score and 205 of these 329 (62%) patients were referred to primary care. The remaining 124 (38%) patients remained in secondary care. Of the 308 (48%) patients with a high score (> 2 points), 265 (86%) remained in secondary care and 41 (14%) were referred to primary care. The primary composite endpoint (mortality, cardiac hospital admissions) occurred more frequently in patients with a high compared to those with a low MIS-HF after 1 year of follow-up (29.2% vs 10.9%; odds ratio (OR) 3.36, 95% confidence interval (CI) 2.20-5.14). No significant difference in the composite endpoint (9.8% vs 12.9%; OR 0.73, 95% CI 0.36-1.47) was found between patients with a low MIS-HF treated in primary versus secondary care.

CONCLUSION: The MIS-HF questionnaire may improve referral policies, as it helps to identify HF patients that can safely be referred to primary care.

© 2022. The Author(s).

Keywords: Consultation; Heart failure; Mortality; Primary health care; Referral

References

  1. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3:7–11. - PubMed
  2. Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428–34. - PubMed
  3. Mosalpuria K, Agarwal SK, Yaemsiri S, et al. Outpatient management of heart failure in the United States, 2006–2008. Tex Heart Inst J. 2014;41:253–61. - PubMed
  4. Lowe J, Candlish P, Henry D, Wlodarcyk J, Fletcher P. Specialist or generalist care? A study of the impact of a selective admitting policy for patients with cardiac failure. Int J Qual Health Care. 2000;12:339–45. - PubMed
  5. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30:518–26. - PubMed
  6. Philbin EF, Weil HF, Erb TA, Jenkins PL. Cardiology or primary care for heart failure in the community setting: process of care and clinical outcomes. Chest. 1999;116:346–54. - PubMed
  7. Luttik ML, Jaarsma T, van Geel PP, et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Fail. 2014;16:1241–8. - PubMed
  8. Schou M, Gustafsson F, Videbaek L, et al. Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar). Eur Heart J. 2013;34:432–42. - PubMed
  9. Engelfriet PM, Haeck J, Wittekoek-Ottevanger L, Veerman J, Schellekens W. Zorg voor hartfalen zonder falen. Indicatoren voor toezicht op de hartfalenketen. 2009. RIVM Rapport 260141001/2009. - PubMed
  10. Kaljouw M, Wijma S. Samenwerken aan passende zorg: de toekomst is nú. Actieplan voor het behoud van goede en toegankelijke gezondheidszorg. : Zorginstituut Nederland; 2020. - PubMed
  11. MacInnes J, Williams L. A review of integrated heart failure care. Prim Health Care Res Dev. 2018;20:e57. https://doi.org/10.1017/S1463423618000312 . - PubMed
  12. Ansink JM, Burgers JS, Geerders BP, Elsendoorn M, van Laarhoven H, Mosterd A. Landelijke Transmurale Afspraak Hartfalen. : Zorginstituut Nederland; 2015. - PubMed
  13. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975. - PubMed
  14. World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4. - PubMed
  15. NHG-Richtlijnen. NHG-Standaard Hartfalen. 2021. https://richtlijnen.nhg.org/standaarden/hartfalen . Accessed: 20.07.2021. - PubMed
  16. Grol R, Braspenning J, Hulscher M, et al. Implementatie van NHG-Standaarden: succes of probleem? HUISARTS WETENSCHAP. 2010;53:42–6. - PubMed
  17. Jong P, Gong Y, Liu PP, Austin PC, Lee DS, Tu JV. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 2003;108:184–91. - PubMed
  18. Barry PP, Crescenzi CA, Radovsky L, Kern DC, Steel K. Why elderly patients refuse hospitalization. J Am Geriatr Soc. 1988;36:419–24. - PubMed
  19. Stewart S, Carrington MJ, Marwick TH, et al. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (which heart failure intervention is most cost-effective & consumer friendly in reducing hospital care) multicenter, randomized trial. J Am Coll Cardiol. 2012;60:1239–48. - PubMed
  20. Kelder JC, Cramer MJ, van Wijngaarden J, et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865–73. - PubMed
  21. Iorio A, Pozzi A, Senni M. Addressing the heterogeneity of heart failure in future randomized trials. Curr Heart Fail Rep. 2017;14:197–202. - PubMed
  22. Shah AM, Solomon SD. Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction. Eur Heart J. 2012;33:1716–7. - PubMed
  23. Albert N, Trochelman K, Li J, Lin S. Signs and symptoms of heart failure: are you asking the right questions? Am J Crit Care. 2010;19:443–52. - PubMed
  24. Abebe TB, Gebreyohannes EA, Tefera YG, Abegaz TM. Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study. BMC Cardiovasc Disord. 2016;16:232. - PubMed
  25. NVVC Connect. Connect 2021–2025 Samen Verbeteren wij de zorg voor hartpatiënten. 2021. https://www.nvvc.nl/PDF/Connect/NVVC%20Connect%202021-2025%20def.pdf . Accessed: 20.07.2021 - PubMed

Publication Types